Literature DB >> 31553901

Affinity Maturation Enhances Antibody Specificity but Compromises Conformational Stability.

Laila Shehata1, Daniel P Maurer1, Anna Z Wec1, Asparouh Lilov1, Elizabeth Champney1, Tingwan Sun1, Kimberly Archambault1, Irina Burnina1, Heather Lynaugh1, Xiaoyong Zhi1, Yingda Xu1, Laura M Walker2.   

Abstract

Monoclonal antibodies (mAbs) have recently emerged as one of the most promising classes of biotherapeutics. A potential advantage of B cell-derived mAbs as therapeutic agents is that they have been subjected to natural filtering mechanisms, which may enrich for B cell receptors (BCRs) with favorable biophysical properties. Here, we evaluated 400 human mAbs for polyreactivity, hydrophobicity, and thermal stability using high-throughput screening assays. Overall, mAbs derived from memory B cells and long-lived plasma cells (LLPCs) display reduced levels of polyreactivity, hydrophobicity, and thermal stability compared with naive B cell-derived mAbs. Somatic hypermutation (SHM) is inversely associated with all three biophysical properties, as well as BCR expression levels. Finally, the developability profiles of the human B cell-derived mAbs are comparable with those observed for clinical mAbs, suggesting their high therapeutic potential. The results provide insight into the biophysical consequences of affinity maturation and have implications for therapeutic antibody engineering and development.
Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  B cells; conformational stability; developability; hydrophobicity; monoclonal antibodies; polyreactivity

Year:  2019        PMID: 31553901     DOI: 10.1016/j.celrep.2019.08.056

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  23 in total

1.  Physicochemical Rules for Identifying Monoclonal Antibodies with Drug-like Specificity.

Authors:  Yulei Zhang; Lina Wu; Priyanka Gupta; Alec A Desai; Matthew D Smith; Lilia A Rabia; Seth D Ludwig; Peter M Tessier
Journal:  Mol Pharm       Date:  2020-06-11       Impact factor: 4.939

Review 2.  Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies.

Authors:  Rahmad Akbar; Habib Bashour; Puneet Rawat; Philippe A Robert; Eva Smorodina; Tudor-Stefan Cotet; Karine Flem-Karlsen; Robert Frank; Brij Bhushan Mehta; Mai Ha Vu; Talip Zengin; Jose Gutierrez-Marcos; Fridtjof Lund-Johansen; Jan Terje Andersen; Victor Greiff
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857

3.  Antibody-Antigen Binding Interface Analysis in the Big Data Era.

Authors:  Pedro B P S Reis; German P Barletta; Luca Gagliardi; Sara Fortuna; Miguel A Soler; Walter Rocchia
Journal:  Front Mol Biosci       Date:  2022-07-14

4.  Microarray-guided evaluation of the frequency, B-cell origins, and selectivity of human glycan-binding antibodies reveals new insights and novel antibodies.

Authors:  J Sebastian Temme; Jennifer A Crainic; Laura M Walker; Weizhun Yang; Zibin Tan; Xuefei Huang; Jeffrey C Gildersleeve
Journal:  J Biol Chem       Date:  2022-09-08       Impact factor: 5.486

5.  Separating clinical antibodies from repertoire antibodies, a path to in silico developability assessment.

Authors:  Christopher Negron; Joyce Fang; Michael J McPherson; W Blaine Stine; Andrew J McCluskey
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 6.440

6.  Evolving Small-Molecule Biosensors with Improved Performance and Reprogrammed Ligand Preference Using OrthoRep.

Authors:  Alex A Javanpour; Chang C Liu
Journal:  ACS Synth Biol       Date:  2021-10-01       Impact factor: 5.249

7.  Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses.

Authors:  Jared Feldman; Julia Bals; Clara G Altomare; Kerri St Denis; Evan C Lam; Blake M Hauser; Larance Ronsard; Maya Sangesland; Thalia Bracamonte Moreno; Vintus Okonkwo; Nathania Hartojo; Alejandro B Balazs; Goran Bajic; Daniel Lingwood; Aaron G Schmidt
Journal:  Sci Immunol       Date:  2021-12-10

Review 8.  Progress toward improved understanding of antibody maturation.

Authors:  Sandor Vajda; Kathryn A Porter; Dima Kozakov
Journal:  Curr Opin Struct Biol       Date:  2021-02-17       Impact factor: 6.809

9.  Near-germline human monoclonal antibodies neutralize and protect against multiple arthritogenic alphaviruses.

Authors:  Ryan J Malonis; James T Earnest; Arthur S Kim; Matthew Angeliadis; Frederick W Holtsberg; M Javad Aman; Rohit K Jangra; Kartik Chandran; Johanna P Daily; Michael S Diamond; Margaret Kielian; Jonathan R Lai
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-14       Impact factor: 11.205

10.  Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein.

Authors:  Anna Z Wec; Daniel Wrapp; Andrew S Herbert; Daniel Maurer; Denise Haslwanter; Mrunal Sakharkar; Rohit K Jangra; M Eugenia Dieterle; Asparouh Lilov; Deli Huang; Longping V Tse; Nicole V Johnson; Ching-Lin Hsieh; Nianshuang Wang; Juergen H Nett; Elizabeth Champney; Irina Burnina; Michael Brown; Shu Lin; Melanie Sinclair; Carl Johnson; Sarat Pudi; Robert Bortz; Ariel S Wirchnianski; Ethan Laudermilch; Catalina Florez; J Maximilian Fels; Cecilia M O'Brien; Barney S Graham; David Nemazee; Dennis R Burton; Ralph S Baric; James E Voss; Kartik Chandran; John M Dye; Jason S McLellan; Laura M Walker
Journal:  bioRxiv       Date:  2020-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.